Literature DB >> 6301989

Macrophage activation in murine African trypanosomiasis.

C M Grosskinsky, R A Ezekowitz, G Berton, S Gordon, B A Askonas.   

Abstract

African trypanosomiasis is accompanied by a profound general immunosuppression in which both suppressive T cells and macrophages (M phi) have been implicated. The present studies define changes in the M phi surface, endocytic and secretory properties, during the infection of mice by Trypanosoma brucei. Peritoneal M phi obtained after the control of the first wave of parasitemia displayed characteristics similar to those activated by intracellular pathogens, such as Mycobacterium bovis bacillus Calmette-Guérin, e.g., the enhanced expression of Ia antigen, decreased M phi-specific antigens, receptors mediating the pinocytosis of mannose-terminal glycoproteins, and an increased ability to secrete plasminogen activator, superoxide anion, and H2O2. Some markers of macrophage activation persisted during the subpatent period before the recurrence of parasitemia, whereas others reverted to normal. Mature T cell function appears not to be essential for M phi activation by T. brucei since the infection of athymic nude mice also induced Ia antigens and plasminogen activator. These studies show that M phi activated by different pathways express common features which may contribute to immune dysfunction observed in trypanosomiasis, as well as in other infections.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6301989      PMCID: PMC348066          DOI: 10.1128/iai.39.3.1080-1086.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  The binding of anti-immunoglobulin antibodies to rat thymocytes and thoracic duct lymphocytes.

Authors:  J C Jensenius; A F Williams
Journal:  Eur J Immunol       Date:  1974-02       Impact factor: 5.532

3.  Immunosuppression in Gambian trypanosomiasis.

Authors:  B M Greenwood; H C Whittle; D H Molyneux
Journal:  Trans R Soc Trop Med Hyg       Date:  1973       Impact factor: 2.184

4.  Immunosuppression during trypanosomiasis.

Authors:  L G Goodwin; D G Green; M W Guy; A Voller
Journal:  Br J Exp Pathol       Date:  1972-02

5.  Activated macrophages in congenitally athymic "nude mice" and in lethally irradiate mice.

Authors:  C Cheers; R Waller
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

6.  Suppression of parasite antigen-specific lymphoid blastogenesis in African trypanosomiasis.

Authors:  Y Charoenvit; G H Campbell; S Tokuda
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

7.  F4/80, a monoclonal antibody directed specifically against the mouse macrophage.

Authors:  J M Austyn; S Gordon
Journal:  Eur J Immunol       Date:  1981-10       Impact factor: 5.532

8.  Macrophage function during Trypanosoma musculi infection in mice.

Authors:  P Vincendeau; A Caristan; R Pautrizel
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

9.  Secretion of plasminogen activator by stimulated macrophages.

Authors:  J C Unkeless; S Gordon; E Reich
Journal:  J Exp Med       Date:  1974-04-01       Impact factor: 14.307

10.  Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor.

Authors:  D I Beller; T A Springer; R D Schreiber
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

View more
  23 in total

1.  In vitro simulation of immunosuppression caused by Trypanosoma brucei.

Authors:  M Sileghem; A Darji; P De Baetselier
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

2.  Granulocyte-macrophage colony-stimulating activity in the serum of mice stimulated with homogenates of Trypanosoma gambiense.

Authors:  M Oka; H Nagasawa; Y Ito; K Himeno
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

3.  Regulation of macrophage accessory cell activity by mycobacteria. II. In vitro inhibition of Ia expression by Mycobacterium microti.

Authors:  P M Kaye; M Sims; M Feldmann
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

4.  Polyclonal B-cell-activating factors produced by spleen cells of mice stimulated with a cell homogenate of Trypanosoma gambiense.

Authors:  M Oka; Y Ito
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

5.  Macrophage signal recognition.

Authors:  D M Weir
Journal:  Agents Actions       Date:  1984-08

6.  In vivo analysis of impaired macrophage bactericidal capacity during experimental African trypanosomiasis.

Authors:  D L Glick; J F Jones
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

7.  Murine macrophages use oxygen- and nitric oxide-dependent mechanisms to synthesize S-nitroso-albumin and to kill extracellular trypanosomes.

Authors:  A P Gobert; S Semballa; S Daulouede; S Lesthelle; M Taxile; B Veyret; P Vincendeau
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Lipid peroxidation in cats experimentally infected with Trypanosoma evansi.

Authors:  Aleksandro Schafer da Silva; Patrícia Wolkmer; Márcio Machado Costa; Francine Paim; Camila Belmonte Oliveira; Régis Adriel Zanette; Janio Morais Santurio; Sonia Terezinha Dos Anjos Lopes; Silvia Gonzalez Monteiro
Journal:  Parasitol Res       Date:  2009-09-30       Impact factor: 2.289

9.  Trypanosoma cruzi but not Trypanosoma brucei fails to induce a chemiluminescent signal in a macrophage hybridoma cell line.

Authors:  B Vray; P De Baetselier; A Ouaissi; Y Carlier
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

10.  Macrophage cytotoxicity in lethal and non-lethal murine malaria and the effect of vaccination.

Authors:  J Taverne; J D Treagust; J H Playfair
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.